Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
Wolfson Building, Newcastle University, Newcastle upon Tyne, UK.
Neuropathol Appl Neurobiol. 2021 Feb;47(1):26-42. doi: 10.1111/nan.12634. Epub 2020 Jun 19.
Neuroferritinopathy (NF) or hereditary ferritinopathy (HF) is an autosomal dominant movement disorder due to mutation in the light chain of the iron storage protein ferritin (FTL). HF is the only late-onset neurodegeneration with brain iron accumulation disorder and study of HF offers a unique opportunity to understand the role of iron in more common neurodegenerative syndromes.
We carried out pathological and biochemical studies of six individuals with the same pathogenic FTL mutation.
CNS pathological changes were most prominent in the basal ganglia and cerebellar dentate, echoing the normal pattern of brain iron accumulation. Accumulation of ferritin and iron was conspicuous in cells with a phenotype suggesting oligodendrocytes, with accompanying neuronal pathology and neuronal loss. Neurons still survived, however, despite extensive adjacent glial iron deposition, suggesting neuronal loss is a downstream event. Typical age-related neurodegenerative pathology was not normally present. Uniquely, the extensive aggregates of ubiquitinated ferritin identified indicate that abnormal FTL can aggregate, reflecting the intrinsic ability of FTL to self-assemble. Ferritin aggregates were seen in neuronal and glial nuclei showing parallels with Huntington's disease. There was neither evidence of oxidative stress activation nor any significant mitochondrial pathology in the affected basal ganglia.
HF shows hallmarks of a protein aggregation disorder, in addition to iron accumulation. Degeneration in HF is not accompanied by age-related neurodegenerative pathology and the lack of evidence of oxidative stress and mitochondrial damage suggests that these are not key mediators of neurodegeneration in HF, casting light on other neurodegenerative diseases characterized by iron deposition.
神经铁蛋白病(NF)或遗传性铁蛋白病(HF)是一种常染色体显性运动障碍,由铁储存蛋白铁蛋白(FTL)的轻链突变引起。HF 是唯一一种具有脑铁蓄积障碍的迟发性神经退行性疾病,对 HF 的研究为理解铁在更常见的神经退行性综合征中的作用提供了独特的机会。
我们对 6 名具有相同致病性 FTL 突变的个体进行了病理和生化研究。
中枢神经系统的病理变化在基底节和小脑齿状核最为明显,与脑铁蓄积的正常模式相呼应。铁蛋白和铁的蓄积在具有少突胶质细胞表型的细胞中非常明显,同时伴有神经元病理和神经元丢失。然而,尽管存在广泛的邻近胶质铁沉积,神经元仍然存活,这表明神经元丢失是下游事件。通常不存在与年龄相关的神经退行性病理。独特的是,大量泛素化铁蛋白的聚集表明异常 FTL 可以聚集,反映了 FTL 自身组装的内在能力。在显示与亨廷顿病平行的神经元和神经胶质核中,均可观察到铁蛋白聚集。受影响的基底节中既没有氧化应激激活的证据,也没有明显的线粒体病理学。
HF 除了铁蓄积外,还具有蛋白质聚集障碍的特征。HF 的退化不伴有与年龄相关的神经退行性病理,并且缺乏氧化应激和线粒体损伤的证据表明,这些不是 HF 神经退行性变的关键介质,为铁沉积特征的其他神经退行性疾病提供了启示。